Bruker (NASDAQ: BRKR) reported Q2 EPS of $0.49, $0.11 better than the analyst estimate of $0.38. Revenue for the quarter came in at $838.5 million versus the consensus estimate of $853.39 million.

GUIDANCE:

Bruker sees FY2026 EPS of $2.10-$2.15, versus the consensus of $2.13. Bruker sees FY2026 revenue of $3.54-3.57 billion, versus the consensus of $3.557 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.